25 May 2013
Keywords: isis, acquires, elan, share, orasense, hepasense, usa-based
Article | 14 June 2004
USA-based Isis Pharmaceuticals has entered into an agreement with a subsidiary of Elan Corp to acquire the latter's minority interest ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
14 June 2004
24 May 2013
© 2013 thepharmaletter.com